Feb 2 |
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
|
Jan 23 |
Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago
|
Dec 14 |
5 Under-$15 Stocks Wall Street Analysts Recommend Buying
|
Dec 13 |
One Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Analyst Just Made A Major Cut To Next Year's Estimates
|
Nov 9 |
Eton Pharmaceuticals, Inc. (ETON) Q3 2023 Earnings Call Transcript
|
Nov 9 |
Eton Pharmaceuticals GAAP EPS of -$0.02, revenue of $7M
|
Nov 9 |
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
|
Nov 8 |
Eton Pharmaceuticals Q3 2023 Earnings Preview
|